Copenhagen University Hospital

Research site

Denmark Ringvej 75, 2730 Herlev, Denmark

6 trials recruiting
Intensive care · Tubulointerstitial nephritis · Osteoporosis
Adults and children

About Specializations

Copenhagen University Hospital in Herlev, Denmark specialises in clinical trials of conditions such as Intensive care, Tubulointerstitial nephritis, Osteoporosis, Critical illness, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Ringvej 752730 HerlevDenmark

Open in maps ↗

Recruiting now: 6 trials
Conditions studied: 8

More sites in Herlev Denmark

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

8 clinical trials

Intensive care

Recruiting

Evaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness

Registered drugNo placebo

Evaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Dalteparin Sodium
Sponsor:Rigshospitalet

Contact Research Centre

Tubulointerstitial nephritis

Recruiting

Study on Prednisolone for Treating Acute Interstitial Nephritis in Patients

Registered drugNo placebo

Study on Prednisolone for Treating Acute Interstitial Nephritis in Patients

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Prednisolone
Sponsor:Region Midtjylland

Contact Research Centre

Osteoporosis

Recruiting

Study on the Effects of Stopping Alendronic Acid in Patients with Osteoporosis

Registered drugNo placebo

Study on the Effects of Stopping Alendronic Acid in Patients with Osteoporosis

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Alendronic Acid
Sponsor:Odense University Hospital

Contact Research Centre

Critical illness

Recruiting

Study on Fluid Removal Using Furosemide and Amiloride Hydrochloride in ICU Patients with Fluid Overload

Registered drug

Study on Fluid Removal Using Furosemide and Amiloride Hydrochloride in ICU Patients with Fluid Overload

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Furosemide
Sponsor:Rigshospitalet

Contact Research Centre

Pneumonia

Recruiting

Study on Inhaled Levofloxacin and Sodium Chloride for Patients with Community-Acquired Pneumonia, Including Those with Pre-existing Lung Disease

Registered drug

Study on Inhaled Levofloxacin and Sodium Chloride for Patients with Community-Acquired Pneumonia, Including Those with Pre-existing Lung Disease

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Levofloxacin
Sponsor:Gentofte Hospital

Contact Research Centre

Breast cancer metastatic

Recruiting

Study Comparing FDG-PET/CT and CT for Monitoring Treatment Response in Patients with Metastatic Breast Cancer Using Fludeoxyglucose (18F)

Registered drugNo placebo

Study Comparing FDG-PET/CT and CT for Monitoring Treatment Response in Patients with Metastatic Breast Cancer Using Fludeoxyglucose (18F)

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Fludeoxyglucose (18F)
Sponsor:Odense University Hospital

Contact Research Centre

Perinatal depression

Not recruiting

Study on Using Estradiol to Prevent Postpartum Depression in Women with a History of the Condition

Registered drug

Study on Using Estradiol to Prevent Postpartum Depression in Women with a History of the Condition

Registered drug

Denmark

Participants:0–17 years · 18–64 years · Healthy volunteers
Substances:Estradiol
Sponsor:Rigshospitalet

Contact Research Centre

Myocardial infarction

Not recruiting

Study on the Effects of Carvedilol, Metoprolol Tartrate, and Bisoprolol Fumarate in Patients After a Heart Attack with Normal Heart Pumping Function

Registered drugNo placebo

Study on the Effects of Carvedilol, Metoprolol Tartrate, and Bisoprolol Fumarate in Patients After a Heart Attack with Normal Heart Pumping Function

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Bisoprolol Fumarate
Sponsor:Frederiksberg Hospital

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites